Japan govt approves stem cell clinical trials

Jul 19, 2013
This file photo, released from Japan's Kyoto University Center for iPS Cell Research and Application (CiRA) on January 23, 2013, shows part of the renal tubule cells (red part) which were differentiated from human stem cells at the CiRA in Kyoto. Japan's government on Friday gave its seal of approval to the world's first clinical trials using stem cells harvested from a patient's own body.

Japan's government on Friday gave its seal of approval to the world's first clinical trials using stem cells harvested from a patient's own body.

Health Minister Norihisa Tamura signed off on a proposal by two research institutes that will allow them to begin tests aimed at treating age-related (AMD), a common medical condition that causes in older people, using "induced Pluripotent Stem (iPS) cells".

Stem cell research is a pioneering field that may offer a cure for conditions that are presently incurable, and scientists hope these clinical trials on a treatment for AMD may offer hope to millions of people robbed of their sight.

A government committee last month approved proposals for the tests, which will be jointly conducted by the Riken Center for Developmental Biology and the Institute of Biomedical Research and Innovation (IBRI) Hospital in the western city of Kobe.

Riken will harvest stem cells, using taken from patients, a spokesman said.

The trial treatment will attempt to create that can be transplanted into the eyes of six patients suffering from AMD, replacing the damaged part of the eye.

The transplant may be conducted as early as the middle of next year at the IBRI Hospital, he said.

AMD, a condition that is incurable at present, affects mostly middle-aged and older people and can lead to blindness. It afflicts around 700,000 people in Japan alone.

Stem cells are infant cells that can develop into any part of the body.

Until the discovery of iPS cells several years ago, the only way to obtain stem cells was to harvest them from .

This is controversial because it requires the destruction of the embryo, a process that religious conservatives, among others, oppose.

Groundbreaking work done in 2006 by Shinya Yamanaka at Kyoto University, a Nobel Laureate in medicine last year, succeeded in generating stem cells from adult skin tissue.

Like , iPS cells are also capable of developing into any cell in the body, but crucially their source material is readily available.

Explore further: Illuminating the dark side of the genome

add to favorites email to friend print save as pdf

Related Stories

Japan OKs world's first iPS stemcell clinical trial

Jun 27, 2013

Japan has given the green light to the world's first clinical trial using stem cells harvested from a patient's own body, officials said Thursday, testing a treatment that may offer hope to millions of people robbed of their ...

Japan researchers close in on stem cell trial

Feb 14, 2013

Researchers in Japan have moved one step closer to clinical trials using adult stem cells in a therapy they hope will prove a cure for common sight problems, an official said Thursday.

Recommended for you

Researchers uncover secrets of internal cell fine-tuning

14 hours ago

New research from scientists at the University of Kent has shown for the first time how the structures inside cells are regulated – a breakthrough that could have a major impact on cancer therapy development.

Microscopic rowing—without a cox

15 hours ago

Many different types of cell, including sperm, bacteria and algae, propel themselves using whip-like appendages known as flagella. These protrusions, about one-hundredth of a millimetre long, function like ...

Illuminating the dark side of the genome

21 hours ago

Almost 50 percent of our genome is made up of highly repetitive DNA, which makes it very difficult to be analysed. In fact, repeats are discarded in most genome-wide studies and thus, insights into this part ...

User comments : 2

Adjust slider to filter visible comments by rank

Display comments: newest first

no fate
not rated yet Jul 19, 2013
Between stem cell research and EM re-gen techniques that are or will be available in the very near future, anyone with a moderate income will be able to extend their health and lifespan signifigantly. Lack of sustainability will offset this for some, but not for all.
El_Nose
not rated yet Jul 19, 2013
how about lack of food and fresh water on the planet being a limiting resource